Sézary syndrome managed with histone deacetylase inhibitor followed by anti-CCR4 monoclonal antibody

2018 ◽  
Vol 43 (3) ◽  
pp. 281-285 ◽  
Author(s):  
T. Numata ◽  
T. Nagatani ◽  
K. Shirai ◽  
T. Maeda ◽  
K. Mae ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
Deacetylase Inhibitor

scholarly journals The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin

PLoS ONE ◽  
2016 ◽  
Vol 11 (1) ◽  
pp. e0146115 ◽  
Author(s):  
Lilach Moyal ◽  
Nataly Feldbaum ◽  
Neta Goldfeiz ◽  
Ada Rephaeli ◽  
Abraham Nudelman ◽  
...  
Keyword(s):  
Histone Deacetylase ◽  
Mycosis Fungoides ◽  
Histone Deacetylase Inhibitor ◽  
Therapeutic Potential ◽  
Sézary Syndrome ◽  
Sezary Syndrome ◽  
Deacetylase Inhibitor

scholarly journals Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers

2014 ◽  
Vol 73 (3) ◽  
pp. 495-501 ◽  
Author(s):  
Jennifer J. Wheler ◽  
Filip Janku ◽  
Gerald S. Falchook ◽  
Tiffiny L. Jackson ◽  
Siqing Fu ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Valproic Acid ◽  
Phase I ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Phase I Study ◽  
Anti Vegf ◽  
Deacetylase Inhibitor

Induction of apoptosis in hepatocellular carcinoma by a novel combination of histone deacetylase inhibitor LBH589

2020 ◽  
Author(s):  
P Mester ◽  
E Aschenbrenner ◽  
C Kunst ◽  
K Gülow ◽  
M Müller-Schilling
Keyword(s):  
Hepatocellular Carcinoma ◽  
Histone Deacetylase ◽  
Histone Deacetylase Inhibitor ◽  
Deacetylase Inhibitor ◽  
Induction Of Apoptosis
Sign in / Sign up

Export Citation Format

Share Document